company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3905000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3905000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3905000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2041000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8722000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10763000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,511000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,132000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7215000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7215000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7215000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6747000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13962000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.82
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.82
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 12:09:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.82
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15012000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15012000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15012000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3096000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11876000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3136000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,435000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1066000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1489000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6756000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-2765000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2344000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9740000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26427000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26427000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26427000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3365000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12276000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14151000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,726000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-355000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1073000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6843000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,5492000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,743000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2438000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 12:49:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4270000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4270000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4270000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3011000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8143000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11154000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6884000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,485000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11149000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11629000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6272000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24785000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4406000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.62
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4406000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.62
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:28:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.62
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4755000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10217000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,446000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14227000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14659000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18110000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18110000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18110000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-1000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-5492000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.41
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.43
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.41
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3307000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3307000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3307000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3750000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11765000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15515000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12208000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,922000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3088000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30321000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3712000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12677000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5000000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21389000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17311000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,740000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,761000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31552000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:31:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3023000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11876000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14899000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11391000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3394000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3419000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31855000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:40:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3739000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3739000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3739000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3714000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14579000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18293000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14554000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3087000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3063000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31515000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4700000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14779000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19479000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15059000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,422000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,485000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32633000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32633000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5717000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5717000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5717000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4661000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14150000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18811000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13094000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,154000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2557000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2711000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10383000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10383000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10383000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10383000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32870000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:01:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4155000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4155000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4155000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5433000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13335000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18768000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14613000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,139000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2616000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2755000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33097000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:21:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3805000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3805000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3805000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5778000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16140000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21918000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18113000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,156000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9122000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8966000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33303000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18201000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18201000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18201000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16246000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22157000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3956000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,334000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8683000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9017000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38666000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3195000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3195000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3195000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6712000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16138000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22850000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19655000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,503000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2864000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2361000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22016000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22016000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22016000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22016000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37272000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3005000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3005000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3005000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6411000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17102000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,512000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-794000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-282000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20790000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-20000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20770000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20770000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20770000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37616000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 07:09:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6263000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19094000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25357000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21987000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,505000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2237000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2742000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19245000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37430000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7836000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21727000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29563000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25858000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,502000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-45000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25401000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38404000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3057000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3057000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3057000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21598000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32968000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,476000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-228000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,248000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29663000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29669000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29669000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29669000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.77
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38631000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:22:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.77
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3014000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3014000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3014000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7533000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21059000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28592000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25578000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,496000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-410000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,86000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25492000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-41000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39361000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 16:13:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3705000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6999000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25342000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32341000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28636000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-309000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,770000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27866000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27927000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27927000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27927000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3232000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3232000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3232000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7441000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30872000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27640000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26209000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26219000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26219000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26219000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45516000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3685000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3685000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3685000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7658000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25933000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33591000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29906000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28927000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45789000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:11:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3258000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3258000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3258000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8653000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24667000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33320000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30062000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1071000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1071000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28991000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-12000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46000000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46000000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46051000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:57:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3816000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3816000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3816000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10751000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29871000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40622000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36806000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5568000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3533000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2035000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34771000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-36000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45898000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10814000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32771000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43585000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40805000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2772000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2772000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38033000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38053000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38053000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38053000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51126000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27666000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27666000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27666000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14037000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34765000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48802000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21136000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3230000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3230000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17906000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-44000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17862000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17862000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17862000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52689000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:11:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4208000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4208000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4208000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15501000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37630000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53131000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48923000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3520000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3520000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45403000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-34000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45369000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45369000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45369000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52800000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52882000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:57:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39339000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39339000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39339000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16133000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48787000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64920000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25581000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10706000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8703000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2003000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23578000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52500000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52453000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
